References
- Moddel G, Bilbao J M, Payne D, Ashby P. Disul-firam neuropathy. Arch Neurol 1978; 35: 658–660
- Watson P C, Ashby P, Bilbao J M. Disulfiram neuropathy. Can Med Assoc 1980; 123: 123–126
- Mokri B, Ohnishi A, Dyck P J. Disulfiram neuropathy. Neurology 1981; 31: 730–735
- Olney K R, Miller R G. Peripheral neuropathy associated with disulfiram administration. Muscle Nerve 1980; 3: 172–174
- Le Quesne P M. Neuropathy due to drugs. Peripheral Neuropathy, Dyck, Thomas, Lambert, Bunge. Vol. 2: 2162–2179
- Asbury K, Brown M J. The evolution of structural changes in distal axonopathies. Experimental and Clinical Neurotoxicology, P S Spencer, H H Schaumburg. Williams & Wilkins, Baltimore 1980; 179–199
- Sabri Ml, Spencer P S. Toxic distal axonopathy. Biochemical studies and hypothetical mechanisms. Experimental and Clinical Neurotoxicology, P S Spencer, H H Schaumburg. Williams & Wilkins, Baltimore 1980; 206–219
- Prickett C S, Johnston C D. The in vivo production of carbon disulfide from tetraethyl thiuram disul-fide (Antabuse). Biochem Biophys Acta 1953; 12: 542–546
- Bouldin T W, Hall C D, Krigman M R. Pathology of disulfiram neuropathy. Neuropathol Appl Neurobiol 1980; 6: 155–160
- Ansbacher L E, Bosch E P, Cancilla P A. Disulfiram neuropathy: A neurofilamentous distal axonopathy. Neurology 1982; 32: 424–428
- Seppalainen A M, Haltia M. Carbon disulfide. Experimental and Clinical Neurotoxicology, P S Spencer, H H Schaumburg. Williams & Wilkins, Baltimore 1980; 356–373
- Spencer P S, Schaumburg H H. Experimental models of primary axonal disease induced by toxic chemicals. Peripheral Neuropathy, Dyck, Thomas, Lampert, Bunge. Saunders, Philadelphia 1984; Vol. 1: 636–649
- Anzil A P. Selected Aspects of experimental disulfiram neuromyopathy. Advances in Neurotoxicology, L Manzo. Pergamon Press, New York 1980; 359–366